Geulah Livshits
Stock Analyst at Chardan Capital
(1.39)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PVLA Palvella Therapeutic... | Maintains: Strong Buy | 50 60 | 41.54 | 44.44% | 2 | Aug 15, 2025 | |
IMRX Immuneering | Maintains: Buy | 13 13 | 3.23 | 302.48% | 13 | Aug 14, 2025 | |
SLDB Solid Biosciences | Maintains: Buy | 15 15 | 6.06 | 147.52% | 8 | Aug 14, 2025 | |
TSHA Taysha Gene Therapie... | Maintains: Strong Buy | 9 10 | 2.75 | 263.64% | 14 | Aug 12, 2025 | |
FDMT 4D Molecular Therape... | Maintains: Buy | 25 25 | 5.53 | 352.08% | 12 | Aug 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 60 | 10.75 | 458.14% | 15 | Aug 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 2.93 | 275.43% | 20 | Aug 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 10 | 3.51 | 184.9% | 6 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 12 | 1.51 | 694.7% | 10 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 20 | 1.97 | 915.23% | 14 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 9 | 0.68 | 1223.53% | 12 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 82 82 | 55.44 | 47.91% | 15 | Aug 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 219 219 | 137.58 | 59.18% | 12 | Aug 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 5.92 | 1927.03% | 5 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 6 | 0.49 | 1124.49% | 6 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 13 12 | 1.81 | 562.98% | 6 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 20 | 4.44 | 350.45% | 9 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 10 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 6 | 1.48 | 305.41% | 5 | Apr 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 41 41 | 7.83 | 423.63% | 4 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 25 | 6.34 | 294.32% | 2 | Mar 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 | 1.32 | 809.09% | 4 | Mar 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 25 | 24.98 | 0.08% | 4 | Mar 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 191 208 | 25.48 | 716.33% | 7 | Jan 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 160 40 | n/a | n/a | 3 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 16 | 1.1 | 1354.55% | 4 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 7.5 | -66.67% | 5 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 450 270 | 0.93 | 28932.26% | 2 | Feb 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 90 | 7.46 | 1106.43% | 1 | Nov 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 3.08 | 29.87% | 3 | Nov 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 3.2 | 525% | 1 | Oct 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 660 600 | n/a | n/a | 2 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 30 | 2.23 | 1245.29% | 1 | Jul 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 9.66 | 86.34% | 1 | Oct 27, 2020 |